Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,824 | 2,823 | 1,834 | 5,814 | 7,847 |
| Receivables | N/A | N/A | N/A | N/A | 58 |
| Other current assets | 156 | 237 | 0 | 225 | 340 |
| TOTAL | $1,980 | $3,060 | $2,374 | $6,039 | $8,245 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 6 | 649 | 701 |
| Intangibles | 0 | 0 | 272 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 121 | 490 | 490 |
| TOTAL | $N/A | $N/A | $399 | $1,138 | $1,190 |
| Total Assets | $1,980 | $3,060 | $2,773 | $7,177 | $9,436 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7 | 298 | 383 | 1,022 | 578 |
| Accrued Expenses | 335 | 428 | 438 | 1,100 | 1,455 |
| TOTAL | $369 | $818 | $821 | $2,847 | $3,523 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 726 | 1,453 |
| Other Non-Current Liabilities | 0 | 0 | 12,136 | 0 | 0 |
| TOTAL | $N/A | $N/A | $12,136 | $N/A | $N/A |
| Total Liabilities | $369 | $818 | $12,958 | $2,847 | $3,523 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 740 | 740 | 740 | 690 | 681 |
| Common Shares | 77 | 77 | 25 | 71 | 71 |
| Retained earnings | -162,924 | -162,246 | -11,357 | -159,611 | -157,605 |
| TOTAL | $1,612 | $2,242 | $-10,185 | $4,330 | $5,913 |
| Total Liabilities And Equity | $1,980 | $3,060 | $2,773 | $7,177 | $9,436 |